EUVIMEDEUVIMED entdecken
Crossref

One Marker for All Territories? Fecal Calprotectin Across the Different Locations of Crohn’s Disease

I Qarch, N Lagdali, S Sabbah, M Kadiri, F Z Chabib, M Borahma, F Z Ajana

Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S566

DOI: 10.1055/s-0046-1821700 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von I Qarch und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Fecal calprotectin is a widely used non-invasive biomarker to assess intestinal inflammation in Crohn’s disease (CD). However, its reliability may vary depending on the anatomical location of disease involvement. The objective of this study was to investigate the correlation between disease location, fecal calprotectin levels, and endoscopic disease activity measured by the Crohn’s Disease Endoscopic Index of Severity (CDEIS).

Methods

We conducted a retrospective study including 172 patients with Crohn’s disease who underwent both fecal calprotectin testing and ileocolonoscopy with CDEIS scoring. Disease locations were classified according to the Montreal classification: L1 (ileal), L2 (colonic), L3 (ileocolonic), L4 (upper gastrointestinal), and L3L4 (combined ileocolonic and upper GI involvement). Statistical analyses were performed using Jamovi software . Spearman’s rank correlation was used to assess the relationship between fecal calprotectin and CDEIS scores, both globally and stratified by disease location. Comparisons of calprotectin and CDEIS values across locations were made using the Kruskal-Wallis test , as data were not normally distributed.

Results

Among the 172 patients included, fecal calprotectin demonstrated a moderate and statistically significant correlation with endoscopic activity across the entire cohort (Spearman’s ρ=0.53, p

Zitieren

APA

Qarch, I., Lagdali, N., Sabbah, S., Kadiri, M., Chabib, F. Z., Borahma, M., & Ajana, F. Z. (2026). One Marker for All Territories? Fecal Calprotectin Across the Different Locations of Crohn’s Disease. Endoscopy, 58(S 03 S 03), S566. https://doi.org/10.1055/s-0046-1821700

Vancouver

Qarch I, Lagdali N, Sabbah S, Kadiri M, Chabib FZ, Borahma M, et al. One Marker for All Territories? Fecal Calprotectin Across the Different Locations of Crohn’s Disease. Endoscopy. 2026;58(S 03 S 03):S566. doi:10.1055/s-0046-1821700

BibTeX
@article{Qarch2026,
  author = {Qarch, I and Lagdali, N and Sabbah, S and Kadiri, M and Chabib, F Z and Borahma, M and Ajana, F Z},
  title = {One Marker for All Territories? Fecal Calprotectin Across the Different Locations of Crohn’s Disease},
  journal = {Endoscopy},
  year = {2026},
  volume = {58},
  number = {S 03 S 03},
  pages = {S566},
  doi = {10.1055/s-0046-1821700}
}
Kostenlos starten →